Abivax S.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
73.90
65.20
-
-
-
99
Cost of Goods Sold (COGS) incl. D&A
6,976.40
9,412.60
-
-
93.00
99
Gross Income
6,902.50
9,347.30
-
-
93.00
99
SG&A Expense
-
-
18,177.00
18,202.00
14,254.00
19,674
EBIT
7,398.10
8,767.70
18,384.00
18,221.00
14,451.00
19,838
Unusual Expense
-
-
-
-
158.00
-
Non Operating Income/Expense
0.80
793.10
286.00
123.00
307.00
715
Interest Expense
168.90
110.80
168.00
30.00
39.00
539
Pretax Income
7,558.10
9,660.70
18,788.00
17,827.00
13,915.00
19,591
Income Tax
1,664.50
1,561.40
2,834.00
3,519.00
2,692.00
3,768
Consolidated Net Income
5,893.50
8,099.40
15,954.00
14,308.00
11,223.00
15,823
Net Income
5,893.50
8,099.40
15,954.00
14,308.00
11,223.00
15,823
Net Income After Extraordinaries
5,893.50
8,099.40
15,954.00
14,308.00
11,223.00
15,823
Net Income Available to Common
5,893.50
8,099.40
15,954.00
14,308.00
11,223.00
15,823
EPS (Basic)
147.34
117.13
1.65
1.48
1.14
1.55
Basic Shares Outstanding
9,624.30
9,624.30
9,653.40
9,652.20
9,870.20
10,175.70
EPS (Diluted)
0.61
0.84
1.47
1.28
1.14
1.55
Diluted Shares Outstanding
9,624.30
9,624.30
10,864.60
11,177.00
9,870.20
10,175.70
EBITDA
7,383.50
8,619.90
18,233.00
18,155.00
14,358.00
19,739
Other Operating Expense
495.70
579.60
56.00
47.00
104.00
65
Non-Operating Interest Income
8.20
10.80
50.00
301.00
110.00
71
About Abivax
View Profile
